2m 2m 2m 2m 2m 2m 2m
Heron Therapeuti (HRTX)
NASDAQ
$0.29-$0.007 (-2.43%)
Price as of Oct 22, 2026 6:24 PM EDT- $64.3MMarket Cap
- -75.11%1-Year Change
- BiotechnologyIndustry
Heron Therapeuti (HRTX)
$0.29-$0.007 (-2.43%)
HRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.30 | ||
Change | -$0.02 (-4.43%) | ||
Open | $0.34 | ||
High | $0.35 | ||
Low | $0.29 | ||
Previous Close | $0.34 | ||
Volume | 4,744,496 | ||
30-Day Average Volume | 2,624,760 | ||
1-Week Change | -6.41% | ||
1-Month Change | 25.48% | ||
1-Year Change | -71.53% | ||
3-Year Change | -44.44% | ||
5-Year Change | -96.67% | ||
Fundamentals | |||
Shares Outstanding | 189.9M | ||
Total Assets | $252.3M | ||
Market Cap | $64.3M | ||
Enterprise Value | $77.5M | ||
Period: QTR TTM FY | |||
Revenue | $37.7M | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$2.3M | ||
EBITDA | -$1.8M | ||
Net Working Capital | $137.7M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 9 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue